trending Market Intelligence /marketintelligence/en/news-insights/trending/EZJGrZg1Q3F_oNwSiA1C2g2 content esgSubNav
In This List

UK regulator investigating Concordia's international business segment

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


UK regulator investigating Concordia's international business segment

Concordia International Corp. said the U.K. Competition and Markets Authority, or CMA, is investigating the company's international segment as well as certain of its products as part of an inquiry related to the U.K.'s pharmaceutical sector.

The company said that the investigation is at an early, information-gathering stage and the CMA has not reached any conclusions on whether any competition law was infringed.

The company said CMA's investigation includes matters that pre-date Concordia's ownership of Amdipharm Mercury Ltd., the segment in question.